The U.S. Nuclear Regulatory Commission is in the process of rescinding or revising guidance and policies posted on this webpage in accordance with Executive Order 14151 Ending Radical and Wasteful Government DEI Programs and Preferencing, and Executive Order 14168 Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government. In the interim, any previously issued diversity, equity, inclusion, or gender-related guidance on this webpage should be considered rescinded that is inconsistent with these Executive Orders.

Frequently Asked Questions About Drug and Urine Specimen Validity Testing

This section provides the NRC staff's answers to the following questions related to drug and urine specimen validity testing, as it relates to fitness-for-duty:

With regard to the drug and alcohol testing provisions, does a descriptive summary document for the 2008 FFD rule exist?

The Federal Register notice for the Part 26 final rule (73 FR 16966), dated March 31, 2008, includes a summary and detailed descriptions of the changes to the drug and alcohol testing requirements. Section VI, page 16997 of the Federal Register Notice contains a "Section-by-Section Analysis of Substantive Changes" from the former rule provisions.

To top of page

Is a licensee testing facility required to include the quality control samples specified in 10 CFR 26.137(e)(6)(i)–(v) in at least one analytical run each quarter or for each analytical run?

10 CFR 26.137(e)(6)(i)-(v) describes the quality control samples that must be included in each analytical runof testing performed at a licensee testing facility.

To top of page

Page Last Reviewed/Updated Tuesday, March 10, 2020